Chinese Single-Dose ‘CanSino’ Vaccine To be Available From April 5: NCOC

Aizbah KhanWeb Editor

03rd Apr, 2021. 07:55 pm
Chinese Single-Dose 'CanSino' Vaccine To be Available From April 5: NCOC

The National Command and Operations Center (NCOC) has been informed that the Chinese single-dose ‘CanSino’ vaccine will be made available to the public in the country from April 5.

The NCOC meeting was chaired by Federal Minister for Planning and Chairman NCOC Asad Umar and National Coordinator NCOC Lt Gen Hamood Uz Zaman Khan.

The meeting was informed that in view of the spread of Coronavirus, 594 more oxygen beds have been added in the health centres reserved for Corona and special attention has been given to Swat and Peshawar for this.

The Forum urges all vaccination centres to ensure that facilities are provided to people over the age of 65 who have already been granted a walk-in vaccination facility.

The meeting was informed that the Chinese one-dose ‘Can Sino’ vaccine will be given to the people in all the provinces of the country from Monday, April 5.

The NCOC also decided to create better monitoring mechanisms to monitor violations of Corona SOPs.

The meeting also considered setting up call centres at the district level for liaison with the registered persons of overage, so as to further improve the vaccination campaign.

It may be recalled that a few days ago, Asad Umar had said that Pakistan and China would import a large number of Coronavirus vaccines, CanSino biologics, of which 3 million doses would be made locally.

In a tweet on the social networking site, he said, “The widely available vaccine doses will be manufactured in Pakistan, for which special equipment has been purchased and staff are being trained.”

Asad Umar said that the first consignment of 60,000 doses of the CanSino vaccine is arriving in Pakistan today. This is the vaccine that Pakistan participated in the third phase of the trial and this was the first time that Pakistan had tested a vaccine. Become a part.

The Cane Sino vaccine is one of four corona vaccines approved by the Drug Regulatory Authority (DRAP).

Other vaccines include China’s Sinopharm, Russia’s Sputnik V and Oxford University-AstraZeneca vaccines.

The company released preliminary results of the vaccine’s efficacy in February after trials in several countries, including Pakistan, which found the vaccine to be 65.7% effective in preventing symptomatic corona cases and 90.98% effective in preventing severe disease.

In Pakistan, the vaccine proved to be 74.8% effective in preventing corona cases with symptoms and 100% effective in preventing severe disease.

 

Adsense 300 x 250